GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 711 filers reported holding GLAXOSMITHKLINE PLC in Q3 2015. The put-call ratio across all filers is 0.70 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $750,000 | -61.8% | 17,378 | -61.6% | 0.04% | -60.2% |
| Q2 2016 | $1,963,000 | -24.6% | 45,301 | -29.4% | 0.10% | -39.1% |
| Q1 2016 | $2,603,000 | +17.9% | 64,193 | +17.3% | 0.17% | +65.7% |
| Q4 2015 | $2,207,000 | -14.6% | 54,707 | -18.6% | 0.10% | -40.7% |
| Q3 2015 | $2,584,000 | -8.8% | 67,196 | -1.2% | 0.17% | -6.5% |
| Q2 2015 | $2,832,000 | +2.5% | 67,983 | +13.6% | 0.18% | +10.8% |
| Q1 2015 | $2,762,000 | +14.9% | 59,852 | +6.4% | 0.17% | +13.7% |
| Q4 2014 | $2,404,000 | -17.8% | 56,248 | -11.6% | 0.15% | -18.4% |
| Q3 2014 | $2,926,000 | +4.7% | 63,654 | +21.8% | 0.18% | +1.1% |
| Q2 2014 | $2,794,000 | -3.4% | 52,247 | -3.5% | 0.18% | -11.1% |
| Q1 2014 | $2,892,000 | +0.6% | 54,139 | +0.6% | 0.20% | 0.0% |
| Q4 2013 | $2,874,000 | +9.6% | 53,828 | +3.0% | 0.20% | +5.9% |
| Q3 2013 | $2,622,000 | -0.2% | 52,256 | -0.6% | 0.19% | -5.5% |
| Q2 2013 | $2,628,000 | – | 52,594 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 325,823 | $11,557,000 | 6.52% |
| KAHN BROTHERS GROUP INC | 1,139,163 | $40,406,111,000 | 6.35% |
| Chubb Ltd | 400,000 | $14,188,000 | 6.18% |
| Healthcare Value Capital, LLC | 50,000 | $1,774,000 | 5.40% |
| CLARK ESTATES INC/NY | 650,000 | $23,056,000 | 3.81% |
| PVG ASSET MANAGEMENT CORP | 220,450 | $7,819,361,000 | 3.57% |
| Martin Capital Partners, LLC | 88,195 | $3,128,000 | 3.25% |
| Camber Capital Management LP | 1,500,000 | $53,205,000 | 2.60% |
| EQUITY INVESTMENT CORP | 2,090,120 | $74,137,000 | 2.47% |
| Keystone Financial Planning, Inc. | 129,102 | $4,579,000 | 2.44% |